Financials
- Market Capitalization 706.56 M
- Employee 40
- Founded 2016
- CEO N/A
- Website www.shattucklabs.com
- Headquarter Delaware, United States
- FIGI BBG00V776CQ7
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-5.21
ratio cours/chiffre d'affaires
253.99
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2674 | GYRE Gyre Therapeutics, Inc. - Common Stock | 6.59 USD | -1.35% | -4.35% | +15.21% | -20.22% | 734.85 M USD | ||
| 2677 | NGNE Neurogene Inc. - Common Stock | 36.58 USD | -3.38% | -5.33% | +8.71% | +24.34% | 732.02 M USD | ||
| 2705 | BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 8.74 USD | -4.79% | -0.91% | +5.68% | -3.10% | 700.72 M USD | ||
| 2706 | CTMX CytomX Therapeutics, Inc. - Common Stock | 3.21 USD | -6.14% | -2.73% | +0.94% | +58.91% | 699.46 M USD |